BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Biotech Beach

  Seven Presentations On electroCore’s Treatment For Cluster Headache And Migraine Will Feature At American Headache Society Science Meeting

  June 6, 2016

   · 

  2 min read
• Deals

  Frontage Laboratories Announces The Acquisition Of Philadelphia And Aurora Facilities From Sun Pharma By Frontage’s Affiliate, Frontida Biopharm

  June 6, 2016

   · 

  3 min read
• Business

  Personalis Announces Partnership With Mt. Sinai Services To Offer Its ACE Platform For Next Generation Sequencing And Interpretation To Support Tumor Molecular Profiling And Immuno-Oncology Clinical Trials In Canada

  June 6, 2016

   · 

  4 min read
• Drug Development

  ASCO2016: AstraZeneca PLC Release: Tagrisso (Osimertinib) Shows Clinical Activity In Patients With Leptomeningeal Disease From Lung Cancer

  June 6, 2016

   · 

  10 min read
• Lone Star Bio

  Waters Corporation Announces New Reference Library For Metabolite Profiling By Ion Mobility Separations

  June 6, 2016

   · 

  2 min read
• BioMidwest

  Acurian, Inc. Receives 2016 Eli Lilly Global Supplier Award

  June 6, 2016

   · 

  3 min read
• Pharm Country

  BioNJ’s Third Annual Diagnostics & Precision Medicine Summit

  June 6, 2016

   · 

  3 min read
• Drug Development

  ASCO2016: Ariad Presents Data From Mutational Profiling In Crizotinib-Resistant Patients Treated With Investigational Medicine Brigatinib Showing Similar Response Rates In Patients With And Without Secondary ALK Mutations

  June 6, 2016

   · 

  5 min read
• Drug Development

  ASCO2016: Leap Therapeutics Presents Data From Phase I Single Dose Safety Study Of Anti-GITR Immunotherapy TRX518 In Patients With Advanced Relapsed Or Refractory Solid Tumors At American Society Of Clinical Oncology (ASCO) 2016 Annual Meeting

  June 6, 2016

   · 

  4 min read
• Drug Development

  ASCO2016: Tyrogenex, Inc. Presents Data Informing Phase II And Supporting Potential Efficacy Of X-82 With Everolimus In Patients With Solid Tumors At The ASCO Annual Meeting 2016

  June 6, 2016

   · 

  2 min read